Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Sep;72(3 Suppl):S38–S45. doi: 10.1136/hrt.72.3_suppl.s38

Renoprotective role of ACE inhibitors in diabetic nephropathy

Carl Erik Mogensen 1
PMCID: PMC1025591  PMID: 7946802

Full text

PDF
S38

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Romeh S. H., Nawaz M. K., Ali J. H., Al-Suhaili A. R., Abu-Jayyab A. K. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy. Clin Nephrol. 1989 Jan;31(1):18–21. [PubMed] [Google Scholar]
  2. Baba T., Murabayashi S., Takebe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia. 1989 Jan;32(1):40–44. doi: 10.1007/BF00265402. [DOI] [PubMed] [Google Scholar]
  3. Bakris G. L. Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathy. Ann Intern Med. 1993 Apr 15;118(8):643–644. doi: 10.7326/0003-4819-118-8-199304150-00013. [DOI] [PubMed] [Google Scholar]
  4. Bangstad H. J., Osterby R., Dahl-Jørgensen K., Berg K. J., Hartmann A., Hanssen K. F. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia. 1994 May;37(5):483–490. doi: 10.1007/s001250050136. [DOI] [PubMed] [Google Scholar]
  5. Bauer J. H., Reams G. P., Hewett J., Klachko D., Lau A., Messina C., Knaus V. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy. Am J Kidney Dis. 1992 Nov;20(5):443–457. doi: 10.1016/s0272-6386(12)70256-1. [DOI] [PubMed] [Google Scholar]
  6. Björck S., Mulec H., Johnsen S. A., Nordén G., Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992 Feb 8;304(6823):339–343. doi: 10.1136/bmj.304.6823.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Björck S., Mulec H., Johnsen S. A., Nyberg G., Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ. 1990 Apr 7;300(6729):904–907. doi: 10.1136/bmj.300.6729.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Björck S., Nyberg G., Mulec H., Granerus G., Herlitz H., Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):471–474. doi: 10.1136/bmj.293.6545.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Borch-Johnsen K., Wenzel H., Viberti G. C., Mogensen C. E. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ. 1993 Jun 26;306(6894):1722–1725. doi: 10.1136/bmj.306.6894.1722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brichard S. M., Santoni J. P., Thomas J. R., van de Voorde K., Ketelslegers J. M., Lambert A. E. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients. Diabete Metab. 1990 Jan-Feb;16(1):30–36. [PubMed] [Google Scholar]
  11. Bursztyn M., Kobrin I., Fidel J., Ben-Ishay D. Improved kidney function with cilazapril in hypertensive type II diabetics with chronic renal failure. J Cardiovasc Pharmacol. 1991 Sep;18(3):337–341. doi: 10.1097/00005344-199109000-00005. [DOI] [PubMed] [Google Scholar]
  12. Chan J. C., Cockram C. S., Nicholls M. G., Cheung C. K., Swaminathan R. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. BMJ. 1992 Oct 24;305(6860):981–985. doi: 10.1136/bmj.305.6860.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cook J., Daneman D., Spino M., Sochett E., Perlman K., Balfe J. W. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr. 1990 Jul;117(1 Pt 1):39–45. doi: 10.1016/s0022-3476(05)82441-2. [DOI] [PubMed] [Google Scholar]
  14. Drummond K., Levy-Marchal C., Laborde K., Kindermans C., Wright C., Dechaux M., Czernichow P. Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children. Diabetologia. 1989 Apr;32(4):255–260. doi: 10.1007/BF00285294. [DOI] [PubMed] [Google Scholar]
  15. Elving L. D., Wetzels J. F., de Nobel E., Hoitsma A. J., Berden J. H. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy. Am J Kidney Dis. 1992 Dec;20(6):559–563. doi: 10.1016/s0272-6386(12)70218-4. [DOI] [PubMed] [Google Scholar]
  16. Elving L. D., Wetzels J. F., van Lier H. J., de Nobel E., Berden J. H. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study. Diabetologia. 1994 Jun;37(6):604–609. doi: 10.1007/BF00403380. [DOI] [PubMed] [Google Scholar]
  17. Fioretto P., Frigato F., Velussi M., Riva F., Muollo B., Carraro A., Brocco E., Cipollina M. R., Abaterusso C., Trevisan M. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens. 1992 Nov;5(11):837–846. doi: 10.1093/ajh/5.11.837. [DOI] [PubMed] [Google Scholar]
  18. Gall M. A., Rossing P., Skøtt P., Damsbo P., Vaag A., Bech K., Dejgaard A., Lauritzen M., Lauritzen E., Hougaard P. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991 Sep;34(9):655–661. doi: 10.1007/BF00400995. [DOI] [PubMed] [Google Scholar]
  19. Gonzalez-Sicilia de Llamas L., Garcia Alberola A., Lafuente Lopez-Herrera M., Fuente Jimenez T., Fernandez Pardo J., Hernandez Cascales J. Effects of captopril on diabetic nephropathy in hypertensive women. Eur J Clin Pharmacol. 1991;41(5):405–409. doi: 10.1007/BF00626360. [DOI] [PubMed] [Google Scholar]
  20. Hallab M., Gallois Y., Chatellier G., Rohmer V., Fressinaud P., Marre M. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. BMJ. 1993 Jan 16;306(6871):175–182. doi: 10.1136/bmj.306.6871.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Holdaas H., Hartmann A., Lien M. G., Nilsen L., Jervell J., Fauchald P., Endresen L., Djøseland O., Berg K. J. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Intern Med. 1991 Feb;229(2):163–170. doi: 10.1111/j.1365-2796.1991.tb00325.x. [DOI] [PubMed] [Google Scholar]
  22. Jenkins D. A., Cowan P., Patrick A. W., Clarke B. F. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study. Nephrol Dial Transplant. 1993;8(3):200–205. [PubMed] [Google Scholar]
  23. Kelleher C. C., Ferriss J. B., Cole M., O'Sullivan D. J. Enalapril and microalbuminuria in diabetic and non-diabetic hypertension. J Hum Hypertens. 1987 Dec;1(3):181–183. [PubMed] [Google Scholar]
  24. Lacourcière Y., Nadeau A., Poirier L., Tancrède G. Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis. Hypertension. 1993 Jun;21(6 Pt 1):786–794. doi: 10.1161/01.hyp.21.6.786. [DOI] [PubMed] [Google Scholar]
  25. Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
  26. Marre M., Chatellier G., Leblanc H., Guyene T. T., Menard J., Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ. 1988 Oct 29;297(6656):1092–1095. doi: 10.1136/bmj.297.6656.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Marre M., Hallab M., Billiard A., Le Jeune J. J., Bled F., Girault A., Fressinaud P. Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes. J Cardiovasc Pharmacol. 1991;18 (Suppl 2):S165–S168. [PubMed] [Google Scholar]
  28. Marre M. Microalbuminuria and ACE inhibition in non-hypertensive diabetics. J Diabet Complications. 1990 Apr-Jun;4(2):84–85. doi: 10.1016/0891-6632(90)90042-4. [DOI] [PubMed] [Google Scholar]
  29. Mathiesen E. R., Hommel E., Giese J., Parving H. H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991 Jul 13;303(6794):81–87. doi: 10.1136/bmj.303.6794.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mimran A., Insua A., Ribstein J., Monnier L., Bringer J., Mirouze J. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens. 1988 Nov;6(11):919–923. doi: 10.1097/00004872-198811000-00011. [DOI] [PubMed] [Google Scholar]
  31. Mogensen C. E. Angiotensin converting enzyme inhibitors and diabetic nephropathy. BMJ. 1992 Feb 8;304(6823):327–328. doi: 10.1136/bmj.304.6823.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mogensen C. E., Hansen K. W., Nielsen S., Pedersen M. M., Rehling M., Schmitz A. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention. Am J Kidney Dis. 1993 Jul;22(1):174–187. doi: 10.1016/s0272-6386(12)70184-1. [DOI] [PubMed] [Google Scholar]
  33. Mogensen C. E. Management of renal disease and hypertension in insulin-dependent diabetes, with an emphasis on early nephropathy. Curr Opin Nephrol Hypertens. 1992 Oct;1(1):106–115. doi: 10.1097/00041552-199210000-00016. [DOI] [PubMed] [Google Scholar]
  34. Molitch M. E. ACE inhibitors and diabetic nephropathy. Diabetes Care. 1994 Jul;17(7):756–760. doi: 10.2337/diacare.17.7.756. [DOI] [PubMed] [Google Scholar]
  35. Morelli E., Loon N., Meyer T., Peters W., Myers B. D. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes. 1990 Jan;39(1):76–82. doi: 10.2337/diacare.39.1.76. [DOI] [PubMed] [Google Scholar]
  36. Nørgaard K., Feldt-Rasmussen B., Borch-Johnsen K., Saelan H., Deckert T. Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990 Jul;33(7):407–410. doi: 10.1007/BF00404089. [DOI] [PubMed] [Google Scholar]
  37. O'Donnell M. J., Rowe B. R., Lawson N., Horton A., Gyde O. H., Barnett A. H. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study. J Hum Hypertens. 1993 Aug;7(4):333–339. [PubMed] [Google Scholar]
  38. O'Donnell M. J., Rowe B. R., Lawson N., Horton A., Gyde O. H., Barnett A. H. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy. J Hum Hypertens. 1993 Aug;7(4):327–332. [PubMed] [Google Scholar]
  39. Olivarius N. de F., Andreasen A. H., Keiding N., Mogensen C. E. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. Diabetologia. 1993 Oct;36(10):1007–1016. doi: 10.1007/BF02374492. [DOI] [PubMed] [Google Scholar]
  40. Osterby R., Gall M. A., Schmitz A., Nielsen F. S., Nyberg G., Parving H. H. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993 Oct;36(10):1064–1070. doi: 10.1007/BF02374500. [DOI] [PubMed] [Google Scholar]
  41. Parving H. H., Hommel E., Damkjaer Nielsen M., Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. BMJ. 1989 Aug 26;299(6698):533–536. doi: 10.1136/bmj.299.6698.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Parving H. H., Hommel E., Smidt U. M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Parving H. H., Kastrup H., Smidt U. M., Andersen A. R., Feldt-Rasmussen B., Christiansen J. S. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia. 1984 Dec;27(6):547–552. doi: 10.1007/BF00276965. [DOI] [PubMed] [Google Scholar]
  44. Pedersen M. M., Christensen C. K., Hansen K. W., Christiansen J. S., Mogensen C. E. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment. Clin Invest Med. 1991 Dec;14(6):642–651. [PubMed] [Google Scholar]
  45. Pedersen M. M., Hansen K. W., Schmitz A., Sørensen K., Christensen C. K., Mogensen C. E. Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy. Kidney Int. 1992 Apr;41(4):883–890. doi: 10.1038/ki.1992.135. [DOI] [PubMed] [Google Scholar]
  46. Pedersen M. M., Schmitz A., Pedersen E. B., Danielsen H., Christiansen J. S. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabet Med. 1988 Sep;5(6):562–569. doi: 10.1111/j.1464-5491.1988.tb01052.x. [DOI] [PubMed] [Google Scholar]
  47. Phillips P. J., Phillipou G., Bowen K. M., Lowe J., Yue D. K., Wischusen J., Pater G. Diabetic microalbuminuria and cilazapril. Am J Med. 1993 Apr 23;94(4A):58S–60S. [PubMed] [Google Scholar]
  48. Ravid M., Savin H., Jutrin I., Bental T., Katz B., Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993 Apr 15;118(8):577–581. doi: 10.7326/0003-4819-118-8-199304150-00001. [DOI] [PubMed] [Google Scholar]
  49. Remuzzi G., Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int. 1990 Sep;38(3):384–394. doi: 10.1038/ki.1990.217. [DOI] [PubMed] [Google Scholar]
  50. Remuzzi G., Ruggenenti P. Slowing the progression of diabetic nephropathy. N Engl J Med. 1993 Nov 11;329(20):1496–1497. doi: 10.1056/NEJM199311113292012. [DOI] [PubMed] [Google Scholar]
  51. Romanelli G., Giustina A., Cimino A., Valentini U., Agabiti-Rosei E., Muiesan G., Giustina G. Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics. BMJ. 1989 Feb 4;298(6669):284–288. doi: 10.1136/bmj.298.6669.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Romanelli G., Giustina A., Cravarezza P., Caldonazzo A., Agabiti-Rosei E., Giustina G. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine. J Hum Hypertens. 1991 Jun;5(3):167–173. [PubMed] [Google Scholar]
  53. Romero R., Salinas I., Lucas A., Abad E., Reverter J. L., Johnston S., Sanmarti A. Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors. Diabetes Care. 1993 Apr;16(4):597–600. doi: 10.2337/diacare.16.4.597. [DOI] [PubMed] [Google Scholar]
  54. Romero R., Salinas I., Teixidó J., Lucas A., Felip A., Sanmarti A. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients. J Hum Hypertens. 1990 Dec;4(6):671–675. [PubMed] [Google Scholar]
  55. Rossing P., Hommel E., Smidt U. M., Parving H. H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes. 1993 May;42(5):715–719. doi: 10.2337/diab.42.5.715. [DOI] [PubMed] [Google Scholar]
  56. Rudberg S., Aperia A., Freyschuss U., Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia. 1990 Aug;33(8):470–476. doi: 10.1007/BF00405108. [DOI] [PubMed] [Google Scholar]
  57. Sampson M. J., Chambers J. B., Sprigings D. C., Drury P. L. Regression of left ventricular hypertrophy with 1 year of antihypertensive treatment in type 1 diabetic patients with early nephropathy. Diabet Med. 1991 Feb-Mar;8(2):106–110. doi: 10.1111/j.1464-5491.1991.tb01554.x. [DOI] [PubMed] [Google Scholar]
  58. Slataper R., Vicknair N., Sadler R., Bakris G. L. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med. 1993 Apr 26;153(8):973–980. [PubMed] [Google Scholar]
  59. Slomowitz L. A., Bergamo R., Grosvenor M., Kopple J. D. Enalapril reduces albumin excretion in diabetic patients with low levels of microalbuminuria. Am J Nephrol. 1990;10(6):457–462. doi: 10.1159/000168169. [DOI] [PubMed] [Google Scholar]
  60. Stornello M., Valvo E. V., Scapellato L. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria. Nephron. 1991;58(1):52–57. doi: 10.1159/000186378. [DOI] [PubMed] [Google Scholar]
  61. Stornello M., Valvo E. V., Scapellato L. Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol. 1989 Dec;14(6):851–855. doi: 10.1097/00005344-198912000-00009. [DOI] [PubMed] [Google Scholar]
  62. Stornello M., Valvo E. V., Scapellato L. Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: comparative effects of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers. Clin Sci (Lond) 1992 Jan;82(1):19–23. doi: 10.1042/cs0820019. [DOI] [PubMed] [Google Scholar]
  63. Taguma Y., Kitamoto Y., Futaki G., Ueda H., Monma H., Ishizaki M., Takahashi H., Sekino H., Sasaki Y. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med. 1985 Dec 26;313(26):1617–1620. doi: 10.1056/NEJM198512263132601. [DOI] [PubMed] [Google Scholar]
  64. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia. 1991 Dec;34(12):877–890. [PubMed] [Google Scholar]
  65. Ueda Y., Aoi W., Yamachika S., Shikaya T. Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension. Nephron. 1990;55 (Suppl 1):85–89. doi: 10.1159/000186043. [DOI] [PubMed] [Google Scholar]
  66. Utsunomiya K., Ikeda Y. Beneficial effect of alacepril, a new angiotensin-converting enzyme inhibitor on albuminuria and glycemic state: an open multicenter trial. Alacepril Study Group. J Diabet Complications. 1991 Apr-Sep;5(2-3):165–166. doi: 10.1016/0891-6632(91)90059-x. [DOI] [PubMed] [Google Scholar]
  67. Valvo E., Bedogna V., Casagrande P., Antiga L., Zamboni M., Bommartini F., Oldrizzi L., Rugiu C., Maschio G. Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations. Am J Med. 1988 Sep;85(3):344–348. doi: 10.1016/0002-9343(88)90584-0. [DOI] [PubMed] [Google Scholar]
  68. Viberti G., Mogensen C. E., Groop L. C., Pauls J. F. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA. 1994 Jan 26;271(4):275–279. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES